Skip to main content

Advertisement

Table 3 Clinical outcomes

From: Safety and efficacy of biocompatible perfusion strategy in a contemporary series of patients undergoing coronary artery bypass grafting – a two-center study

Outcome Observed rate (n = 964) STS expected rate* n = 964)
30-day mortality 14 (1.4%) 2.0%
Reoperation for bleeding 41 (4.2%) 6.0%
Postoperative stroke 9 (0.9%) 1.0%
Postoperative sternal infection 18 (1.9%) 0.5%
Postoperative renal failure 71 (7.4%) 3.0%
Postoperative MI 13 (1.3%)  
Postoperative atrial fibrillation 241 (25%)  
Time on the respirator (hours) 14 ± 29 (8, 2–432)  
ICU length of stay (hours) 74 ± 73 (48, 0–1008)  
Hospital length of stay (days) 8 ± 7 (10, 2–142)  
  1. *Predicted outcome rate based on the American Society of Thoracic Surgeons Database risk-assessment algorithms [13].